The Early Diagnosis of Hypothyroidism as a Factor in the Progression of Osteoarthritis and Comorbid Processes, the Features of Phytocorrection
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 7, Issue 79
Abstract
Objective: to study the prevalence and forms of hypothyroidism in patients with osteoarthritis (OA) and to investigate the effect of phytomedication zobofit on the functional and morphological status of the thyroid gland, the manifestations of comorbid diseases, oxidative status, fibrinolytic and proteolytic activity of the blood. Materials and methods. In 312 patients with OA, we have studied the manifestations of comorbid processes, and among them — hypothyroidism phenomena. We have used clinical, biochemical, radioimmunological, ultrasound methods. Results. All patients with OA after 50 years had the increasing number and severity of comorbid processes. Among them, 4.48 % of patients has symptomatic and 13.78 % — subclinical hypothyroidism. Symptoms of hypothyroidism were marked in people over 55, especially — over 60 years. Subclinical hypothyroidism slightly worsened clinical symptoms of OA and comorbid processes, but enhanced the effects of oxidative stress, reduction of fibrinolytic and increase of proteolytic activity of the blood, impaired glomerular filtration rate of the kidneys. The above is considered as non-specific pathophysiological basis for the progression of identified ailments. Three-month application of the herbal medication zobofit in most patients has normalized thyroid homeostasis, improved overall outcomes of the treatment for underlying and comorbid illnesses, reduced the severity of metabolic disorders. Conclusions. In OA patients aged over 50 years with a high level of comorbidity, it is necessary to carry out screening for hypothyroidism. If you noticed the signs of subclinical hypothyroidism in this population of patients, it is appropriate to use multicomponental phytomedications with diverse thyroid-stimulating action.
Authors and Affiliations
L. O. Voloshynа
Keywords
Related Articles
- EP ID EP177642
- DOI 10.22141/2224-0721.7.79.2016.86424
- Views 82
- Downloads 0
Experience of Modern Premixed Insulin Use in Treatment of Diabetes Mellitus
No abstract
Features of pahogocytic activity of monocytes and neutrophils in patients with obesity and ankylosinig spondylitis depending on HLA B27 gene carrier
Background. Ankylosing spondylitis (AS) is a widespread pathology all over the world. The AS prevalence in different countries ranges from 0.2 to 2 %. Usually the disease debuts at the age of 20–40 years, men suffer from...
Quality of life of patients with bronchial asthma combined with obesity, depending on the identification of FTO RS9939609 and RS324011 STAT6 gene polymorphism
Background. We purposed to analyse the distribution of polymorphism of the FTO and STAT6 genes and the quality of life in patients with bronchial asthma (BA) combined with obesity. Materials and methods. 117 people aged...
Using ultra-rapid insulin analogs in children and adolescents with type 1 diabetes mellitus
Background. The purpose of the study was a retrospective comparative analysis of using insulin analogues of the prolonged and ultra-short action and human genetically engineered insulins of middle and short action in chi...
Lifestyle Changes in as a Prevention of Diabetes Mellitus
Insulin resistance is not only the cause of carbohydrate intolerance and diabetes mellitus type 2, but also the factor of the development of cardiovascular diseases. However, we are faced with the fact that patients are...